Literature DB >> 1555870

Insulin resistance versus insulin secretion in the hypertension of obesity.

N W Istfan1, C S Plaisted, B R Bistrian, G L Blackburn.   

Abstract

We measured the degree of association between obesity, blood pressure, insulin resistance, and insulin secretion in 72 male and female obese hypertensive, obese nonhypertensive, and normal weight control subjects. Baseline weight, body mass index, percent body fat, waist/hip ratio, and systolic and diastolic blood pressures were obtained. Insulin sensitivity was assessed according to Bergman's minimal model. Twelve-hour urinary c-peptide was measured after a standard liquid meal. Insulin action was inversely associated with blood pressure status, obesity status, and age. Meal-stimulated c-peptide excretion significantly correlated with systolic blood pressure and percent fat but not with body mass index or age. Multivariate regression analysis indicated that, of the measures of body composition, percent fat and waist/hip ratio had the strongest correlation with insulin action either alone or in combination with c-peptide excretion. Obese hypertensive patients had an index of insulin action (10(-4).min-1/[microunits/ml]) of 1.34 +/- 0.19, which was significantly (p less than 0.003) lower than in the obese nonhypertensive patients (index, 2.26 +/- 0.10) or the nonobese subjects (index, 5.41 +/- 0.26, p less than 0.001). Meal-stimulated c-peptide excretion (nmol/kg lean body mass) was increased only in the obese hypertensive group (0.32 +/- 0.01) and was significantly higher (p less than 0.001) than in the obese nonhypertensive (0.16 +/- 0.01) or the nonobese subjects (0.14 +/- 0.01). These results support the hypothesis that abnormalities in blood pressure regulation, insulin-stimulated glucose uptake, and insulin secretion coexist.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555870     DOI: 10.1161/01.hyp.19.4.385

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Obesity, hypertension, and vascular disease.

Authors:  K M Sowers; J R Sowers
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 2.  Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Authors:  David C Henderson
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Authors:  David C Henderson
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

4.  Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults: Longitudinal Observation From the Bogalusa Heart Study.

Authors:  Tao Zhang; Huijie Zhang; Shengxu Li; Ying Li; Yaozhong Liu; Camilo Fernandez; Emily Harville; Lydia Bazzano; Jiang He; Wei Chen
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

5.  Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension.

Authors:  M de Courten; P Ferrari; M Schneider; L Böhlen; S Shaw; W Riesen; G Heynen; P Weidmann
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  The pathogenesis of hypertension in obese subjects.

Authors:  P Weidmann; M de Courten; L Boehlen; S Shaw
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  A critical role of the mechanosensor PIEZO1 in glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Yingying Ye; Mohammad Barghouth; Haiqiang Dou; Cheng Luan; Yongzhi Wang; Alexandros Karagiannopoulos; Xiaoping Jiang; Ulrika Krus; Malin Fex; Quan Zhang; Lena Eliasson; Patrik Rorsman; Enming Zhang; Erik Renström
Journal:  Nat Commun       Date:  2022-07-22       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.